Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Coccidioides immitis spherule is a skin antigen test for delayed-type hypersensitivity to Coccidioides immitis. A skin test for an immune system reaction to a certain infection.
- Mechanism
- Curator reviewed
Delayed type hypersensitivity reaction begin with the C.immitis antigen is presented to CD4 and CD8 lymphocytes by antigen presenting cells. This causes the secretion of interleukins and other lymphokines from macrophage cells. The release of effector molecules causes blood vessels to become permeable and allows fibrinogen to escape into the surrounding tissue where it is converted to fibrin. The deposition of fibrin and the movement of T-cells and monocytes in the extracellular spaces cause the tissue to become indurated. The induration is usually detectable in 18 hours and peaks at 48 hours.
- Primary indication
- Indicated to detect delayed-type hypersensitivity to Coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis.Curator reviewed · 2 structured indications
- First approval
- United States, 2011
- Brand names
- Spherusol
Resolves to
What you can answer from here — as of April 02, 2025
Which drugs share a target with Coccidioides immitis spherule, and which of those have an active Phase 3 trial?